CRC Screening in Unscreened Individuals 45-54
Launched by MASSACHUSETTS GENERAL HOSPITAL · Dec 26, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the challenges and supports related to colorectal cancer (CRC) screening for individuals aged 45 to 54. The study aims to find out what makes it easier or harder for people in this age group to get screened for cancer. Participants will take part in one-time interviews, either online or in person, and staff from community health centers will complete an online survey about their experiences with CRC screening.
To be eligible for this study, patients must be between 45 and 54 years old, be patients at the health center, and be willing to provide consent. However, those with a personal or family history of colorectal cancer, or certain other health conditions, cannot participate. On the staff side, anyone aged 18 and older who works at the health center and is involved in CRC screening can take part. The insights from this study will help improve screening processes and support for people in this important age group.
Gender
ALL
Eligibility criteria
- • PATIENTS
- Inclusion Criteria:
- • Individuals aged 45-54
- • Individuals who are patients at the health center
- • Individuals that are willing and able to give verbal/written consent
- Exclusion Criteria:
- • Individuals with a personal history of CRC
- • Individuals with a family history of CRC
- • Individuals with a history of inflammatory bowel disease or high-risk cancer syndrome
- • STAFF
- Inclusion Criteria:
- • Individuals ages 18+
- • Individuals working at the health center
- • Individuals that are involved in CRC screening processes at CSHC
- • Individuals that are willing and able to give verbal/written consent
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Adjoa Anyane-Yeboa, MD, MPH
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported